Browse Studies — Arctuva

Phase 3

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Once-Daily Oral Orforglipron Compared With Placebo in Individuals With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

This study will evaluate the efficacy and safety of orforglipron in participants with overweight and assess whether it helps reduce the future risk of obesity-…

OverweightPrediabetic StatePrehypertension+1 more

Estimated

~$10 – $7,500

Eli Lilly and CompanyNCT07794579

Observational

Mechanisms of Sympathetic Overactivity in Post-traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is a highly prevalent anxiety disorder that is associated with an increased risk of cardiovascular (CV) disease and hyper…

Post-traumatic Stress DisorderPrehypertension

Estimated

~$10 – $6,250

Emory UniversityNCT01627301

Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study

The Fit2Lead prospective cohort study examines the effects of a park-based youth mental health and resilience afterschool program on youth participant mental h…

AnxietyWellness, PsychologicalOverweight or Obesity+3 more

Documented

$9

Duke UniversityNCT06596265

Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study

The Fit2Play prospective cohort study examines the effects of a park-based youth physical activity afterschool program on youth participant fitness and mental …

OverweightObesityHypertension+6 more

Estimated

~$10 – $750

Duke UniversityNCT06595251